- ►annals.org WH Maisel, KM Kuntz, SC Reimold, TH Lee, … - Annals of internal medicine, 1997 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: The risks of antiarrhythmic therapy are increasingly ... Cited by 99 - Related articles - BL Direct - All 3 versions
- ►onlinejacc.org MK Chung, RA Schweikert, BL Wilkoff, MJ … - Journal of the American College of Cardiology, 1998 - Elsevier Objectives. We sought to determine the yield of in-hospital monitoring for
detection of significant arrhythmia complications in patients starting sotalol
therapy for atrial arrhythmias and to identify factors that might predict ... Cited by 49 - Related articles - BL Direct - All 9 versions
RH Falk - Annals of internal medicine, 1992 - Am Coll Physicians ▪ Data Sources: English-language literature from the early 1960s to the
present was identified by manual search of the literature; relevant articles
were reviewed. Pertinent earlier studies were identified from references in ... Cited by 135 - Related articles - All 4 versions
MD Simons, R Grant, DBA Eisenstein, L Eric, … - The American journal of cardiology, 1997 - Elsevier This study assessed the cost effectiveness of inpatient antiarrhythmic therapy
initiation for supraventricular tachycardias using a metaanalysis of
proarrhythmic risk and a decision analysis that compared inpatient to ... Cited by 33 - Related articles - BL Direct - All 5 versions
SH Hohnloser, A van de Loo, F Baedeker - Journal of the American College of Cardiology, 1995 - Elsevier Quinidine was more effective than sotalol in terminating atrial fibrillation
(60% vs. 20%, p = 0.009). When nonresponders to drug therapy underwent
subsequent direct current cardioversion, total conversion rates in the ... Cited by 158 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org [PDF] S Juul-Moller, N Edvardsson, N Rehnqvist- … - Circulation, 1990 - Am Heart Assoc Steen Juul-Moller, MD, PhD, Nils Edvardsson, MD, PhD, and Nina
Rehnqvist-Ahlberg, MD, PhD* ... This open, parallel-group study compares
quinidine and sotalol treatment for maintenance of Cited by 307 - Related articles - All 5 versions
EN Prystowsky - Clinical Cardiology, 1994 - interscience.wiley.com In-hospital initiation of antiarrhythmic drug therapy is often recommended to
observe the effects of the drug and monitor for possible adverse reactions,
especially proarrhythmia. However, the actual risk of proarrhythmia in ... Cited by 31 - Related articles - BL Direct - All 3 versions
GC Flaker, JL Blackshear, R McBride, RA … - Journal of the American College of Cardiology, 1992 - Am Coll Cardio Found BACKGROUND AND OBJECTIVES. The relation between cardiac mortality and
antiarrhythmic drug administration has not been fully determined. This relation
was analyzed in 1,330 patients enrolled in the Stroke Prevention in Atrial ... Cited by 430 - Related articles - All 3 versions
RH Falk, A Pollak, SN Singh, T Friedrich - Journal of the American College of Cardiology, 1997 - Am Coll Cardio Found OBJECTIVES: This study sought to determine the safety and efficacy of a single
bolus of intravenous dofetilide, a pure class III antiarrhythmic agent, for the
termination of sustained atrial fibrillation or flutter. BACKGROUND: ... Cited by 160 - Related articles - BL Direct - All 4 versions
PJ Zimetbaum, VE Schreckengost, DJ Cohen, … - The American journal of cardiology, 1999 - Elsevier The decision to maintain sinus rhythm after conversion from atrial fibrillation
(AF) usually requires the initiation of antiarrhythmic medications. Previous
studies demonstrated that patients with AF are at risk of serious ... Cited by 12 - Related articles - BL Direct - All 5 versions
